HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Theuer Selected Research

Tyrosine Kinase Inhibitors

3/2008Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Theuer Research Topics

Disease

3Neoplasms (Cancer)
01/2016 - 01/2006
2Melanoma (Melanoma, Malignant)
03/2008 - 01/2006
1Lymphatic Metastasis
03/2008
1Neoplasm Metastasis (Metastasis)
03/2008

Drug/Important Bio-Agent (IBA)

2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 03/2008
1LigandsIBA
03/2008
1vatalanib (PTK787)IBA
03/2008
1Tyrosine Kinase InhibitorsIBA
03/2008
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
03/2008
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2008
1PlatinumIBA
03/2008
1Blocking AntibodiesIBA
03/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2008
1Sphingosine-1-Phosphate ReceptorsIBA
01/2006
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2006

Therapy/Procedure

1Drug Therapy (Chemotherapy)
03/2008